← Browse by Condition
Medical Condition
myelodysplastic syndrome mds
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1
NCT07008820
Recruiting
Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan
Enrollment
50 pts
Location
Japan
Sponsor
Bristol-Myers Squibb
NCT05534620 Phase 1
Recruiting
Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics
Enrollment
36 pts
Location
United States
Sponsor
medac GmbH
NCT05143996 Phase 1
Recruiting
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Enrollment
60 pts
Location
United States
Sponsor
Cullinan Therapeutics Inc.